A Study to Evaluate TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis

A Randomized, Double-Masked, Dose-Ranging Study to Evaluate the Safety and Tolerability of TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis.

The objective of this study is to evaluate the safety of TRS01 eye drops in participants with active non-infectious anterior uveitis

.

Inclusion Criteria:

• 18 years of age or older
• Able to provide informed consent, follow instructions and complete all required study visits for the duration of the study.
• Diagnosed with active non-infectious anterior uveitis requiring an increase or initiation of topical steroids for management of ocular inflammation.

An eligible subject must have:

• Non-infectious active anterior uveitis with anterior chamber cells Grade 2 or Grade 3, as specified per protocol.
• Must have vision ≥ 20/40 in the non-study eye.
• Use adequate birth control by men and women, if of reproductive potential and sexually active, as specified per protocol.

Exclusion Criteria:

• Any form of infectious uveitis
• Active retinitis
• Cancer or melanoma that is actively treated with immunotherapy
• Pregnancy / lactation
• Receiving specific medication/interventions as specified per protocol